NOELLE HEBGEN: Open Payments
NPI 1497399208 · PLATTEVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 35 payments from 12 companies in 2025. Trend: 2023 $470 · 2024 $634 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $147 |
| ABBVIE INC. | 5 | $108 |
| Lundbeck LLC | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Sage Therapeutics, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
Products named: VRAYLAR, REXULTI, LYBALVI, TRINTELLIX, ABILIFY ASIMTUFII, INGREZZA, ARISTADA, SPRAVATO.
Industry payments across WI — which companies pay providers there.
